Literature DB >> 15073529

Amyloid-beta down-regulates XIAP expression in human SH-SY5Y neuroblastoma cells.

Hidenaga Yamamori1, Toshihisa Tanaka, Takashi Kudo, Masatoshi Takeda.   

Abstract

Recent observations suggest that amyloid-beta (Abeta), a major constituent of senile plaques, induces apoptosis in cultured neuronal cells. However, the concentration of Abeta that leads to neuronal cell death is much higher (10-25 microM) than that in the cerebrospinal fluid of normal controls or AD patients (nM order). As reported here, we found that subtoxic concentrations (100-500 nM) of Abeta(1-42) can down-regulate the expression of the X-linked inhibitor of apoptosis (XIAP) in human SH-SY5Y neuroblastoma cells, and that vulnerability to oxidative stress caused by Abeta(1-42) is attenuated by over-expression of XIAP. These results suggest that down-regulation of XIAP expression in response to subtoxic, more physiological concentrations (100-500 nM) of Abeta(1-42) increases vulnerability to oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073529     DOI: 10.1097/00001756-200404090-00023

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

Review 1.  Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics.

Authors:  Hyomin Jeong; Heewon Shin; Seungpyo Hong; YoungSoo Kim
Journal:  Exp Neurobiol       Date:  2022-04-30       Impact factor: 3.800

Review 2.  Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review.

Authors:  Ovais Shafi
Journal:  BMC Neurol       Date:  2016-11-22       Impact factor: 2.474

3.  Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer's Disease.

Authors:  Hasan Turkez; Ivana Cacciatore; Lisa Marinelli; Erika Fornasari; Mehmet Enes Aslan; Kenan Cadirci; Cigdem Yuce Kahraman; Ozge Caglar; Abdulgani Tatar; Giuseppe Di Biase; Ahmet Hacimuftuoglu; Antonio Di Stefano; Adil Mardinoglu
Journal:  Biomolecules       Date:  2021-01-19

4.  Identification of prefrontal cortex protein alterations in Alzheimer's disease.

Authors:  Maria Garranzo-Asensio; Pablo San Segundo-Acosta; Javier Martínez-Useros; Ana Montero-Calle; María Jesús Fernández-Aceñero; Anna Häggmark-Månberg; Alberto Pelaez-Garcia; Mayte Villalba; Alberto Rabano; Peter Nilsson; Rodrigo Barderas
Journal:  Oncotarget       Date:  2018-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.